“…Previous research suggests that CANTAB is a suitable method to measure cognitive functions in 4-to 90-year-old individuals, particularly in people with Alzheimer's, Parkinson's disease, schizophrenia, and autism (Lowe & Rabbitt, 1998;Luciana, 2003). Studies have also demonstrated that it is sensitive to deficits due to several neuropsychological and psychiatric conditions, especially in the elderly (e.g., Blackwell et al, 2003;Levaux et al, 2007;Robbins et al, 1998;Sahakian & Owen, 1992), but also in children (e.g., Gau & Shang, 2010;Fried, Hirshfeld-Becker, Petty, Batchelder, & Biederman, 2012;Luciana, Lindeke, Georgieff, Mills, & Nelson, 1999;Rhodes, Riby, Matthews, & Coghill, 2011).…”